Last reviewed 2026-04-20 · How we verify

BCG Vaccine AJVaccines

University of Zurich · Phase 2 active Biologic Quality 0/100

BCG Vaccine AJVaccines is a Biologic drug developed by University of Zurich. It is currently in Phase 2 development.

At a glance

Generic name	BCG Vaccine AJVaccines
Sponsor	University of Zurich
Modality	Biologic
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

BCG Vaccination Effect on Latent Reservoir Size in Treated HIV-1 Infection: (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

BCG Vaccine AJVaccines CI brief — competitive landscape report
BCG Vaccine AJVaccines updates RSS · CI watch RSS
University of Zurich portfolio CI

Frequently asked questions about BCG Vaccine AJVaccines

What is BCG Vaccine AJVaccines?

BCG Vaccine AJVaccines is a Biologic drug developed by University of Zurich.

Who makes BCG Vaccine AJVaccines?

BCG Vaccine AJVaccines is developed by University of Zurich (see full University of Zurich pipeline at /company/university-of-zurich).

What development phase is BCG Vaccine AJVaccines in?

BCG Vaccine AJVaccines is in Phase 2.

Manufacturer: University of Zurich — full pipeline
Compare: BCG Vaccine AJVaccines vs similar drugs
Pricing: BCG Vaccine AJVaccines cost, discount & access